This article provides a comprehensive evaluation of long-term stability in antifouling biosensor coatings, a critical factor for reliable performance in biomedical diagnostics and drug development.
Emerging contaminants (ECs)—including pharmaceuticals, pesticides, microplastics, and endocrine-disrupting chemicals—pose a significant threat to environmental and human health, driving the need for advanced monitoring solutions.
The translation of biosensor technology from research laboratories to clinical and field applications hinges on robust performance in complex, real-world matrices.
This article provides a detailed comparative analysis of antibody and aptamer biosensors, focusing on the critical parameter of specificity for researchers and drug development professionals.
This article provides a comprehensive guide for researchers and drug development professionals on validating the specificity of biosensors against established gold standard methods like ELISA and HPLC.
This article provides a comprehensive comparison of specific and selective sensing approaches, crucial for researchers and professionals in drug development.
This article provides a comprehensive analysis of ascorbic acid (AA) interference in biosensing, a critical challenge for researchers and drug development professionals working with electrochemical detection systems.
This article provides a comprehensive analysis of the critical yet often conflated concepts of specificity and selectivity in biosensors, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive comparison of drift compensation algorithms for electrochemical biosensors, addressing a critical challenge that limits their reliability in research and clinical applications.
Signal drift is a critical non-ideal effect that compromises the long-term accuracy and reliability of urea biosensors, particularly in clinical and research settings.